-
1
-
-
33644837942
-
Non-steroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics
-
Ulrich CM, Bigler J, Potter JD,. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006; 6: 130-40.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 130-140
-
-
Ulrich, C.M.1
Bigler, J.2
Potter, J.D.3
-
2
-
-
0037180757
-
Inflammation and cancer
-
Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7.
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
3
-
-
79955564023
-
Intestinal inflammation and cancer
-
Ullman TA, Itzkowitz SH,. Intestinal inflammation and cancer. Gastroenterology 2011; 140: 1807-16.
-
(2011)
Gastroenterology
, vol.140
, pp. 1807-1816
-
-
Ullman, T.A.1
Itzkowitz, S.H.2
-
4
-
-
33646875285
-
Meta-analysis: Colorectal and small bowel cancer risk in patients with Crohn's disease
-
Canavan C, Abrams KR, Mayberry J,. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharm Ther 2006; 23: 1097-104.
-
(2006)
Aliment Pharm Ther
, vol.23
, pp. 1097-1104
-
-
Canavan, C.1
Abrams, K.R.2
Mayberry, J.3
-
5
-
-
34248157118
-
Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies
-
Flossmann E, Rothwell PM,. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-13.
-
(2007)
Lancet
, vol.369
, pp. 1603-1613
-
-
Flossmann, E.1
Rothwell, P.M.2
-
6
-
-
60749128400
-
Aspirin for the chemoprevention of colorectal adenomas: Meta-analysis of the randomized trials
-
Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 2009; 101: 256-66.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 256-266
-
-
Cole, B.F.1
Logan, R.F.2
Halabi, S.3
-
7
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741-50.
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
-
8
-
-
79960059582
-
Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort
-
Ruder EH, Laiyemo AO, Graubard BI, et al. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011; 106: 1340-50.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 1340-1350
-
-
Ruder, E.H.1
Laiyemo, A.O.2
Graubard, B.I.3
-
9
-
-
0033545342
-
Acute-phase proteins and other systemic responses to inflammation
-
Gabay C, Kushner I,. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
-
(1999)
N Engl J Med
, vol.340
, pp. 448-454
-
-
Gabay, C.1
Kushner, I.2
-
10
-
-
1642533465
-
Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: A comparison of monozygotic and dizygotic twins
-
MacGregor AJ, Gallimore JR, Spector TD, et al. Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 2004; 50: 130-4.
-
(2004)
Clin Chem
, vol.50
, pp. 130-134
-
-
Macgregor, A.J.1
Gallimore, J.R.2
Spector, T.D.3
-
11
-
-
0021910942
-
Comparative study of serum amyloid A protein and C-reactive protein in disease
-
Maury CP,. Comparative study of serum amyloid A protein and C-reactive protein in disease. Clin Sci (Lond) 1985; 68: 233-8.
-
(1985)
Clin Sci (Lond)
, vol.68
, pp. 233-238
-
-
Maury, C.P.1
-
12
-
-
0020636591
-
Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease
-
Raynes JG, Cooper EH,. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol 1983; 36: 798-803.
-
(1983)
J Clin Pathol
, vol.36
, pp. 798-803
-
-
Raynes, J.G.1
Cooper, E.H.2
-
13
-
-
70249127607
-
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients
-
Pierce BL, Ballard-Barbash R, Bernstein L, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009; 27: 3437-44.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3437-3444
-
-
Pierce, B.L.1
Ballard-Barbash, R.2
Bernstein, L.3
-
14
-
-
1342288777
-
C-reactive protein and the risk of incident colorectal cancer
-
Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer. J Am Med Assoc 2004; 291: 585-90.
-
(2004)
J Am Med Assoc
, vol.291
, pp. 585-590
-
-
Erlinger, T.P.1
Platz, E.A.2
Rifai, N.3
-
15
-
-
26444586236
-
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort
-
Il'yasova D, Colbert LH, Harris TB, et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 2413-8.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 2413-2418
-
-
Il'Yasova, D.1
Colbert, L.H.2
Harris, T.B.3
-
16
-
-
33644533143
-
A prospective study of serum C-reactive protein and colorectal cancer risk in men
-
Gunter MJ, Stolzenberg-Solomon R, Cross AJ, et al. A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 2006; 66: 2483-7.
-
(2006)
Cancer Res
, vol.66
, pp. 2483-2487
-
-
Gunter, M.J.1
Stolzenberg-Solomon, R.2
Cross, A.J.3
-
17
-
-
33646271843
-
Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study
-
Otani T, Iwasaki M, Sasazuki S, et al. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev 2006; 15: 690-5.
-
(2006)
Cancer Epidemiol Biomarkers Prev
, vol.15
, pp. 690-695
-
-
Otani, T.1
Iwasaki, M.2
Sasazuki, S.3
-
18
-
-
79951617570
-
Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study
-
Prizment AE, Anderson KE, Visvanathan K, et al. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev 2011; 20: 297-307.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 297-307
-
-
Prizment, A.E.1
Anderson, K.E.2
Visvanathan, K.3
-
19
-
-
14844355637
-
C-reactive protein levels are not associated with increased risk for colorectal cancer in women
-
Zhang SM, Buring JE, Lee IM, et al. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 2005; 142: 425-32.
-
(2005)
Ann Intern Med
, vol.142
, pp. 425-432
-
-
Zhang, S.M.1
Buring, J.E.2
Lee, I.M.3
-
20
-
-
26244451635
-
Colorectal cancer and serum C-reactive protein levels: A case-control study nested in the JACC Study
-
Ito Y, Suzuki K, Tamakoshi K, et al. Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC Study. J Epidemiol 2005; 15: S185-9.
-
(2005)
J Epidemiol
, vol.15
-
-
Ito, Y.1
Suzuki, K.2
Tamakoshi, K.3
-
21
-
-
34247155282
-
C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: The Rotterdam Study
-
Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol 2006; 24: 5216-22.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5216-5222
-
-
Siemes, C.1
Visser, L.E.2
Coebergh, J.W.3
-
22
-
-
58249122522
-
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: Findings from two prospective cohorts and a meta-analysis
-
Heikkila K, Harris R, Lowe G, et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2009; 20: 15-26.
-
(2009)
Cancer Causes Control
, vol.20
, pp. 15-26
-
-
Heikkila, K.1
Harris, R.2
Lowe, G.3
-
23
-
-
65549122953
-
Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer
-
Allin KH, Bojesen SE, Nordestgaard BG,. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009; 27: 2217-24.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2217-2224
-
-
Allin, K.H.1
Bojesen, S.E.2
Nordestgaard, B.G.3
-
24
-
-
79952284479
-
Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs
-
quiz e11
-
Chan AT, Ogino S, Giovannucci EL, et al. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology 2011; 140: 799-808, quiz e11.
-
(2011)
Gastroenterology
, vol.140
, pp. 799-808
-
-
Chan, A.T.1
Ogino, S.2
Giovannucci, E.L.3
-
25
-
-
47249136072
-
C-reactive protein and colorectal cancer risk: A systematic review of prospective studies
-
Tsilidis KK, Branchini C, Guallar E, et al. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 2008; 123: 1133-40.
-
(2008)
Int J Cancer
, vol.123
, pp. 1133-1140
-
-
Tsilidis, K.K.1
Branchini, C.2
Guallar, E.3
-
26
-
-
77955899767
-
Circulating C-reactive protein concentrations and risks of colon and rectal cancer: A nested case-control study within the European Prospective Investigation into Cancer and Nutrition
-
Aleksandrova K, Jenab M, Boeing H, et al. Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol 2010; 172: 407-18.
-
(2010)
Am J Epidemiol
, vol.172
, pp. 407-418
-
-
Aleksandrova, K.1
Jenab, M.2
Boeing, H.3
-
27
-
-
80054119245
-
Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
-
Toriola AT, Ulrich CM,. Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer? Future Oncol 2011; 7: 1125-8.
-
(2011)
Future Oncol
, vol.7
, pp. 1125-1128
-
-
Toriola, A.T.1
Ulrich, C.M.2
-
28
-
-
42949127635
-
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
-
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
-
(2008)
Gastroenterology
, vol.134
, pp. 1570-1595
-
-
Levin, B.1
Lieberman, D.A.2
McFarland, B.3
-
30
-
-
0142217570
-
The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures
-
Langer RD, White E, Lewis CE, et al. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003; 13: S107-21.
-
(2003)
Ann Epidemiol
, vol.13
-
-
Langer, R.D.1
White, E.2
Lewis, C.E.3
-
31
-
-
6844255857
-
The Women's Health Initiative Study Group
-
Design of the Women's Health Initiative clinical trial and observational study
-
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998; 19: 61-109.
-
(1998)
Control Clin Trials
, vol.19
, pp. 61-109
-
-
-
32
-
-
10744233268
-
Outcomes ascertainment and adjudication methods in the Women's Health Initiative
-
Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003; 13: S122-8.
-
(2003)
Ann Epidemiol
, vol.13
-
-
Curb, J.D.1
McTiernan, A.2
Heckbert, S.R.3
-
33
-
-
0031839899
-
The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study
-
Poole S, Walker D, Gaines Das RE, et al. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods 1998; 214: 1-10.
-
(1998)
J Immunol Methods
, vol.214
, pp. 1-10
-
-
Poole, S.1
Walker, D.2
Gaines Das, R.E.3
-
34
-
-
31844456870
-
Rapid recycling of cholesterol: The joint biologic role of C-reactive protein and serum amyloid A
-
Manley PN, Ancsin JB, Kisilevsky R,. Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A. Med Hypotheses 2006; 66: 784-92.
-
(2006)
Med Hypotheses
, vol.66
, pp. 784-792
-
-
Manley, P.N.1
Ancsin, J.B.2
Kisilevsky, R.3
-
35
-
-
0025553450
-
Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen
-
Schultz DR, Arnold PI,. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 1990; 20: 129-47.
-
(1990)
Semin Arthritis Rheum
, vol.20
, pp. 129-147
-
-
Schultz, D.R.1
Arnold, P.I.2
-
36
-
-
58149515783
-
Serum amyloid A: An acute-phase protein involved in tumour pathogenesis
-
Malle E, Sodin-Semrl S, Kovacevic A,. Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci 2009; 66: 9-26.
-
(2009)
Cell Mol Life Sci
, vol.66
, pp. 9-26
-
-
Malle, E.1
Sodin-Semrl, S.2
Kovacevic, A.3
-
37
-
-
79960715096
-
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer
-
Pine SR, Mechanic LE, Enewold L, et al. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. J Natl Cancer Inst 2011; 103: 1112-22.
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1112-1122
-
-
Pine, S.R.1
Mechanic, L.E.2
Enewold, L.3
|